Unique ID issued by UMIN | UMIN000010387 |
---|---|
Receipt number | R000012153 |
Scientific Title | Study on the usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms caused by peripheral intravenous administration of oxaliplatin |
Date of disclosure of the study information | 2013/04/01 |
Last modified on | 2013/04/01 17:19:35 |
Study on the usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms caused by peripheral intravenous administration of oxaliplatin
usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms by of Oxaliplatin i.v
Study on the usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms caused by peripheral intravenous administration of oxaliplatin
usefulness and safety of warmied infusions and local hot fomentations for vascular pain-like symptoms by of Oxaliplatin i.v
Japan |
Colorectal cancer patient
Nursing |
Malignancy
NO
This study evaluates decrease of vascular pain-like symptoms of peripheral intravenous administration of oxaliplatin. The techniques to be used are the warming infusions with hot pack and the step-by-step local hot fomentations.
Safety
Confirmatory
Pragmatic
NRS:Numeric Rating Scale
enquetes
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Maneuver |
1st time chemotherapy
1. During heating is described in the report
2. If vascular pain happened, then the warming infusion is start.
3. NRS is performed for 5min, 10min, 15min. Subsequent check is performed every 15 minutes..
4. Patient's report is performed from day 1 to day 8.
Subsequently
1. Patients select one of the following before the start of infusion.
i) Warming infusion is performed from the time of the appearance of vascular pain.
ii) Performed prophylactically from the beginning.
Not select all.
20 | years-old | <= |
79 | years-old | >= |
Male and Female
1) Colorectal cancer patients treated with oxaliplatin by peripheral intravenous drip
2) Written patient consent was obtained from patients.
3) XELOX,XELOX+BV or SOX,SOX+BV
4) 20-79 years, gender does not matter
1)Patients with paresthesia or hemiplegia
2)Patient whose conscious level is not clear
3)Patients who are taking Celecoxib
Extension for vascular pain of the time of administration, increased lysates, mixed injection of dexamethasone
10
1st name | |
Middle name | |
Last name | Ryoko Kato |
Yokohama city university hospital
Outpatient chemotherapy room
3-9 Fukuura, Kanazawa-Ku, Yokohama, Japan
045-787-2800
1st name | |
Middle name | |
Last name | Ryoko Kato |
Yokohama city university hospital
Outpatient chemotherapy room
3-9 Fukuura, Kanazawa-Ku, Yokohama, Japan
045-787-2800
Yokohama city university hospital
None
Self funding
NO
2013 | Year | 04 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2012 | Year | 12 | Month | 03 | Day |
2013 | Year | 02 | Month | 01 | Day |
2016 | Year | 03 | Month | 01 | Day |
2013 | Year | 04 | Month | 01 | Day |
2013 | Year | 04 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012153